Equity Risk Partners Leads Insurance Due Diligence for Gryphon Investors' Acquisition of C.B. Fleet Co.

Healthcare and Life Sciences

Company: C.B. Fleet Co. is a consumer healthcare manufacturer and marketer of personal care and over-the-counter products in the feminine hygiene, gastrointestinal, and infant care categories. Founded in 1869 by Charles Browne Fleet and based in Lynchburg, VA, Fleet started out as a small pharmacy providing novel, easy-to-use personal health and beauty merchandise. Today, Fleet Laboratories is a global provider of more than 100 personal health and beauty products. The Company's product lines include Summer's Eve® feminine hygiene products, the Fleet® disposable enema, Norforms® feminine deodorant suppositories, Pedia-Lax® laxatives for children, Phazyme® anti-gas medication, and the Boudreaux's® brand of baby products.

Investor: Based in San Francisco, Gryphon Investors focuses on leveraged acquisitions of, and growth investments in, middle-market companies in partnership with experienced management teams. With more than $1.4 billion of cumulative equity commitments, Gryphon has an extensive track record of investing up to $100 million of its committed capital per investment in companies with sales ranging from approximately $100 to $500 million. Gryphon prioritizes investment opportunities where it can form proactive partnerships with owners and executives to build leading companies, utilizing Gryphon's capital, professional resources and operational expertise.

If you would like more information please contact Michael Marcon at or (415) 874-7101.

To learn more about Equity Risk Partners, visit